GeneDx Holdings Corp. Strategic Asset Allocation Index
GeneDx Holdings Corp. strategic asset allocation index. GeneDx Holdings Corp. (WGS) has a Strategic Asset Allocation Index of 26.0% as of June 2023. Strategic assets (PP&E of $77.02 Million plus long-term investments of $-) total $77.02 Million, measured against net assets of $296.11 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check GeneDx Holdings Corp. tangible net worth ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of GeneDx Holdings Corp. (2020–2022)
Strategic asset allocation index of GeneDx Holdings Corp. from 2020 to 2022. This chart shows how GeneDx Holdings Corp.'s Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of June 2023, the index stands at 26.0%, representing strategic assets of $77.02 Million against net assets of $296.11 Million USD.
GeneDx Holdings Corp. Strategic Asset Allocation Index by Year (2020–2022)
GeneDx Holdings Corp. strategic asset allocation index by year from 2020 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for GeneDx Holdings Corp. from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of GeneDx Holdings Corp..
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 33.2% | $84.28 Million | $84.28 Million | $- | $253.71 Million | ▲ +17.1 pp |
| 2021 | 16.2% | $62.72 Million | $62.72 Million | $- | $388.10 Million | ▼ -1422.1 pp |
| 2020 | 1438.2% | $63.11 Million | $63.11 Million | $- | $4.39 Million | — |